Literature DB >> 17141362

Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002.

Vincent D Criscione1, Martin A Weinstock.   

Abstract

BACKGROUND: The epidemiology of dermatofibrosarcoma protuberans (DFSP) has not been studied in detail.
OBJECTIVE: We sought to describe patterns of DFSP incidence and survival in the United States.
METHODS: Data were obtained from 9 population-based cancer registries of the Surveillance, Epidemiology, and End Results Program for 1973 to 2002.
RESULTS: DFSP overall annual incidence was 4.2 per million. Incidence increased by 43% (3.1-4.4 per million per year) during the study period, but this increase was restricted to whites. Annual incidence among blacks (6.5 per million) was almost double the incidence among whites (3.9 per million; P < .005, 95% confidence interval of difference 2.02-3.22). Women had higher rates of incidence than men (4.4 vs 4.2 per million per year; P = .052, 95% confidence interval of difference -0.002 to 0.60), except among the elderly. Relative 5-year survival was 99.2% (95% confidence interval 98.3-100%). LIMITATIONS: The Surveillance, Epidemiology, and End Results Program lacks independent verification of diagnoses and case detail.
CONCLUSIONS: The racial differences in the incidence of DFSP are significant, and the cause is unknown. Previous literature had suggested that men were more frequently affected, which was not true in our data. The tumor rarely results in death. Epidemiologic investigation using population-based data is important to better understand this disorder.

Entities:  

Mesh:

Year:  2006        PMID: 17141362     DOI: 10.1016/j.jaad.2006.09.006

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  60 in total

1.  Late Recurrence of Dermatofibrosarcoma Protuberans in a Previously Skin Grafted Forearm.

Authors:  Michael P Gaspar; Geneviève Landes; A Lee Osterman
Journal:  J Hand Microsurg       Date:  2015-10-29

2.  Recurrent dermatofibrosarcoma protuberans: A continuing problem.

Authors:  Manisha Makkar; Dayal Pratap Singh; Akshay Rana; Mayank Madan
Journal:  Indian Dermatol Online J       Date:  2013-01

3.  Dermatofibrosarcoma Protuberans Male Breast: A Case report.

Authors:  Tahir Iqbal Mirza; Kaleem Akhtar; Hussan Burair Abbas; Mubashra Sameena; Fasiha Tahir; Saleem Khan; Akeel Ur Rehman Bhutto
Journal:  Oman Med J       Date:  2011-09

Review 4.  The Surveillance, Epidemiology, and End Results (SEER) Program and Pathology: Toward Strengthening the Critical Relationship.

Authors:  Máire A Duggan; William F Anderson; Sean Altekruse; Lynne Penberthy; Mark E Sherman
Journal:  Am J Surg Pathol       Date:  2016-12       Impact factor: 6.394

5.  Dermatofibrosarcoma protuberans: a case report and review of the literature.

Authors:  D Paramythiotis; G Stavrou; D Panagiotou; G Petrakis; A Michalopoulos
Journal:  Hippokratia       Date:  2016 Jan-Mar       Impact factor: 0.471

6.  Soft tissue tumors of the anorectum: rare, complex and misunderstood.

Authors:  Mohammed O Nassif; Nora H Trabulsi; Kelli M Bullard Dunn; Ayoub Nahal; Ari-Nareg Meguerditchian
Journal:  J Gastrointest Oncol       Date:  2013-03

7.  Intracranial recurrence and distant metastasis of scalp dermatofibrosarcoma protuberans.

Authors:  Jurica Marakovic; Milorad Vilendecic; Tonko Marinovic; Smiljka Lambasa; Gordan Grahovac
Journal:  J Neurooncol       Date:  2008-03-15       Impact factor: 4.130

8.  Dermatofibrosarcoma protuberans: A case report of a rare, bulky tumor that was managed with surgical therapy.

Authors:  Ahmet Yılmaz; Erol Cenesizoglu; Ertuğrul Eğilmez; Safa Onel; Mehdi Muştu; Ahmet Cennet
Journal:  Int J Shoulder Surg       Date:  2009-01

9.  Dermatofibrosarcoma protuberans in a 10-year-old child.

Authors:  Uwe Wollina
Journal:  J Dermatol Case Rep       Date:  2013-12-30

Review 10.  Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations.

Authors:  Cyril Fisher
Journal:  Virchows Arch       Date:  2009-04-28       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.